Citadel Advisors’s Bio Green Med Solution Inc BGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.5K | Buy |
75,240
+53,189
| +241% | +$51.3K | ﹤0.01% | 12949 |
|
|
2026
Q1 | $22.1K | Buy |
+22,051
| New | +$24.4K | ﹤0.01% | 12651 |
|
|
2025
Q3 | – | Sell |
-11,970
| Closed | -$59.3K | – | 12956 |
|
|
2025
Q2 | $59.3K | Buy |
11,970
+11,754
| +5,442% | +$427K | ﹤0.01% | 11685 |
|
|
2025
Q1 | $14.5K | Buy |
+216
| New | +$17.7K | ﹤0.01% | 13361 |
|
|
2024
Q3 | – | Sell |
-51
| Closed | -$19.9K | – | 14371 |
|
|
2024
Q2 | $19.9K | Buy |
+51
| New | +$24.5K | ﹤0.01% | 12647 |
|
|
2023
Q4 | – | Sell |
-9
| Closed | -$10.7K | – | 14393 |
|
|
2023
Q3 | $10.7K | Buy |
9
+6
| +200% | +$10.5K | ﹤0.01% | 13049 |
|
|
2023
Q2 | $6.76K | Buy |
3
+2
| +200% | +$4.46K | ﹤0.01% | 13401 |
|
|
2023
Q1 | $2.59K | Sell |
1
-4
| -80% | -$11.9K | ﹤0.01% | 14127 |
|
|
2022
Q4 | $11.5K | Buy |
+5
| New | +$18.4K | ﹤0.01% | 13569 |
|
|
2022
Q2 | – | Sell |
-6
| Closed | -$36.3K | – | 13039 |
|
|
2022
Q1 | $71K | Buy |
6
+3
| +100% | +$36.4K | ﹤0.01% | 12562 |
|
|
2021
Q4 | $40K | Sell |
3
-27
| -90% | -$433K | ﹤0.01% | 13366 |
|
|
2021
Q3 | $563K | Sell |
30
-40
| -57% | -$769K | ﹤0.01% | 9582 |
|
|
2021
Q2 | $1.49M | Sell |
70
-12
| -15% | -$297K | ﹤0.01% | 7338 |
|
|
2021
Q1 | $2.09M | Buy |
+82
| New | +$2.31M | ﹤0.01% | 6278 |
|
|
2019
Q2 | – | Hold |
0
| – | -$11K | – | 9258 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 9142 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 8910 |
|
|
2018
Q3 | – | Hold |
0
| – | -$19K | – | 9270 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 8660 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$108K | – | 8339 |
|
|
2017
Q4 | $108K | Buy |
+1
| New | +$131K | ﹤0.01% | 7404 |
|
|
2016
Q2 | – | Hold |
0
| – | -$15K | – | 6899 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6545 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7827 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 8066 |
|
|
2015
Q1 | – | Hold |
0
| – | -$19K | – | 8561 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 7842 |
|
Other funds holding BGMS
TRCT
SS
AIC
Citadel Advisors's BGMS Position: Q2 2026 in Review
Citadel Advisors increased its Bio Green Med Solution Inc (BGMS) stake by 241% in Q2 2026, buying an estimated $51.3K and bringing the position to 75,240 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12949.
Citadel Advisors first reported a position in BGMS in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.09M in Q1 2021. 7 funds tracked by Wall St. Rank hold BGMS as of Q2 2026.
- Citadel Advisors held 75,240 shares of Bio Green Med Solution Inc worth $68.5K as of Q2 2026.
- Citadel Advisors bought 53,189 Bio Green Med Solution Inc shares in Q2 2026, an estimated $51.3K.
- Bio Green Med Solution Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12949 holding.
- Citadel Advisors first reported a position in Bio Green Med Solution Inc in Q4 2017 and has held it in 15 quarters since.
- Citadel Advisors's Bio Green Med Solution Inc position peaked at $2.09M in Q1 2021.
- 7 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.